UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round


Sid Martin Biotech , the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc ., has closed on a $30 million investment round. Lacerta is a clinical-stage gene therapy company using a constellation of proprietary adeno-associated virus vector technologies to develop treatments for central nervous system and lysosomal storage diseases.



from Biotech News